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Abstract
Background: Polymorphonuclear neutrophil granulocytes (PMN) are phagocytes of the first line
of antimicrobial defense. Previously we demonstrated that lipoteichoic acid (LTA) from
Staphylococcus aureus (S. aureus) directly activates neutrophil granulocytes. Others have reported
that exposure of S. aureus to β-lactam antibiotics leads to LTA release. In the present study we
addressed the question whether exposure of S. aureus to β-lactam antibiotics or antibiotics of other
groups results in the generation of PMN-stimulating activity and whether this activity can be
attributed to LTA.
Methods:  S. aureus were exposed to flucloxacillin, a β-lactam antibiotic or to the protein
synthesis-inhibitors erythromycin and gentamicin, or to ciprofloxacin, a gyrase inhibitor.
Supernatants of the antibiotic-treated bacteria were assayed for their LTA content and for their
effect on PMN functions.
Results: We observed that exposure of S. aureus to flucloxacillin and, to a lesser degree to
ciprofloxacin, but not to erythromycin or gentamicin led to LTA release. Co-incubation of
neutrophil granulocytes with LTA-containing supernatants led to PMN activation as assed by
morphological changes, release of IL-8, delay of spontaneous apoptosis and enhanced phagocytic
activity. Depletion of LTA from the supernatants markedly reduced their PMN-activating capacity.
Conclusion: The findings suggest that, via the activation of PMN, antibiotic-induced LTA release
from S. aureus leads to enhanced antimicrobial activity of the innate immune defense mechanisms.
Background
Gram-positive bacteria are responsible for 50 % of bacte-
rial infections. Stapyhylococcus aureus (S. aureus) is a major
human pathogenic gram-positive bacterium causing a
diverse array of diseases ranging from minor skin and
wound diseases to more serious and life-threatening dis-
eases like pneumonia, endocarditis and arthritis [1]. S.
aureus, as all gram-positive bacteria, has a thick cell wall of
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peptidoglycan which covers a thin cytoplasmic mem-
brane. Several compounds such as teichoic acid, lipogly-
cans, polysaccharides and lipoteichoic acid (LTA) are
incorporated in the peptidoglycan exoskeleton. LTA is a
major immunostimulatory component of S. aureus. In a
previous study we demonstrated that highly purified LTA
from S. aureus directly activated polymorphonuclear neu-
trophil granulocytes (PMN) resulting in morphological
changes, shedding of CD62L, degranulation, cytokine
release, priming of fMLP-mediated oxidative burst and
delay in the spontaneous apoptosis [2]. Neutrophil gran-
ulocytes are phagocytes of the innate immune system that
participate in inflammatory reactions as first line of
defense against microbial pathogens. Since neutropenic
patients are prone to S. aureus infections, and neutrophil
granulocytes are able to phagocytose and kill S. aureus in
vitro [3], PMN have long been thought to provide signifi-
cant host defense against this pathogen.
Previous studies from other laboratories indicated that
certain antibiotics mainly β-lactam compounds induce
LTA release from the gram-positive bacteria Streptococcus
pneumoniae [4] and S. aureus [5,6] whereas protein synthe-
sis inhibitors did not lead to enhanced LTA release [6].
Based on the two previous findings that i) supernatants of
β-lactam antibiotic-treated S. aureus contain LTA and ii)
purified  S. aureus LTA can activate neutrophils, in the
present study we addressed the hypothesis whether super-
natants of β-lactam antibiotic-treated S. aureus can
directly activate neutrophil granulocytes. The experiments
revealed a marked activation of PMN by the supernatants,
i.e. the cells acquired an activated cell shape, released IL-
8, their spontaneous apoptosis was delayed and their
phagocytic activity was enhanced. The major neutrophil
activating component in the supernatants was LTA since
depletion of LTA markedly reduced the PMN-activating
effect of the supernatants. These data suggest that treat-
ment of S. aureus infections with β-lactam antibiotics, in
addition to the direct antibacterial activity, has an activat-
ing effect on the innate immune system.
Methods
Isolation of human peripheral blood neutrophil 
granulocytes
Peripheral blood was collected by venipuncture from
healthy adult volunteers using lithium-heparin. Blood
was layered on a two-layer density gradient consisting of
lymphocyte separation medium 1077 (upper layer, PAA,
Pasching, Austria) and Histopaque® 1119 (bottom layer,
Sigma, Deisenhofen, Germany) and centrifuged for 5 min
at 300 × g followed by 20 min at 800 × g. Cells from the
upper layer consisting mainly of lymphocytes and mono-
cytes were discarded. The granulocyte-rich lower layer was
collected leaving the erythrocyte pellet at the bottom of
the tube. Granulocytes were washed once in PBS, resus-
pended in complete medium (RPMI 1640 medium,
(Sigma) supplemented with 50 μM 2-mercaptoethanol, 2
mM L-glutamine, 10 mM HEPES (all from Biochrom, Ber-
lin, Germany)) and 10 % fetal calf serum (FCS, Gibco,
Karlsruhe, Germany) and further fractionated on a dis-
continuous Percoll®  (Amersham Biosciences, Uppsala,
Sweden) gradient consisting of layers with densities of
1.105 g/ml (85 %), 1.100 g/ml (80 %), 1.087 g/ml (70
%), and 1.081 g/ml (65 %). After centrifugation for 20
min at 800 × g, the interface between the 80 and 70 % Per-
coll® layers was collected, the cells were washed once in
PBS and resuspended in complete medium to a concen-
tration of 5 × 106/per ml. All procedures were conducted
under sterile conditions at room temperature. The cell
preparations contained > 99.9 % granulocytes as deter-
mined by morphological examination of > 1,000 cells on
Giemsa stained cytocentrifuge (Shandon, Pittsburgh, PA)
slides. Cell viability was > 99 %, as determined by trypan
blue exclusion.
Cell culture
PMN were cultured at a concentration of 5 × 106 cells per
ml in complete medium (see above) at 37°C in a humid-
ified atmosphere containing 5 % CO2 in tissue culture
plates with 96 flat-bottom wells (Greiner, Frickenhausen,
Germany). The cells were coincubated for the indicated
time points with the bacterial supernatants (see below) or
with 10 μg/ml of highly purified S. aureus LTA [7]. The
morphology of PMN in the cell culture was monitored
using an invert microscope and documented by digital
imaging (Carl Zeiss, Jena, Germany).
Staphylococcus aureus
S. aureus DSM 20233 strain (DSMZ, Braunschweig, Ger-
many) was cultured using Columbia sheep (COS) blood
agar plate (Bio Mérieux, Marcy I'Etoite, France) and incu-
bated at 37°C. The bacteria were resuspended in complete
medium and quantified by densitometry (Densimat, Bio
Mérieux) using McFarland standards (McFarland of 0.5
corresponds to approximately 1.5 × 108 bacteria/ml).
Morphological assessment of PMN apoptosis
Apoptotic PMN exhibit typical morphological features
such as condensation of the nuclear chromatin and sepa-
ration of darkly stained pyknotic nuclear lobes [8,9].
Using these morphological criteria the percentage of
apoptotic PMN was determined in cultures exposed to S.
aureus supernatants. Nuclear morphology was assessed on
Giemsa-stained cytocentrifuge slides. Cell morphology
was examined under oil immersion light microscopy
(Carl Zeiss). A minimum of 200 cells/slide were examined
and graded as apoptotic/nonapoptotic.Annals of Clinical Microbiology and Antimicrobials 2006, 5:15 http://www.ann-clinmicrob.com/content/5/1/15
Page 3 of 10
(page number not for citation purposes)
Determination of IL-8 in the supernatants of PMN cultures
Cell free supernatants from PMN cultures (5 × 106 cells/
ml) were collected after indicated time points and stored
at -20°C until cytokine determination. IL-8 was measured
using an enzyme-linked immunosorbent assay (ELISA,
CytoSets™, Biosource, Camarillo, CA) according to the
manufacturer's instructions. The detection limit was 30
pg/ml.
Analysis of the phagocytic activity of PMN
To determine the phagocytic activity, PMN were incu-
bated for 75 min at 37°C in a 96-well flat-bottom tissue
culture plate (i) in medium without antibiotics, or (ii) in
medium with flucloxacillin (FLU, 2.5 μg/ml, correspond-
ing to 20 × minimal inhibitory concentration (MIC),
Stapylex®  Injection, GlaxoSmithKline, Munich, Ger-
many), or (iii) in medium containing highly purified S.
aureus LTA [7] (10 μg/ml) or (iv) in a supernatant of flu-
cloxacillin-treated  S. aureus (see below). Subsequently,
viable S. aureus of three strains (the reference strain DSM
20233 and two clinical isolates) were added at a bacte-
rium to PMN ratio of 3:1 and the uptake of bacteria was
assessed after incubation for 30 min at 37°C. The number
of PMN with phagocytosed S. aureus was assessed on
Giemsa-stained cytocentrifuge slides under oil immersion
light microscopy. The samples were blinded and scored by
two independent investigators. A minimum of 500 cells/
slide were examined and the ratio of PMN with phagocy-
tosed bacteria was determined.
Generation of bacterial supernatants
The susceptibility of S. aureus to the four antibiotics flu-
cloxacillin, erythromycin (ERY, Sigma), gentamicin
(GEN, Sigma) and ciprofloxacin (CIP, Ciprobay® 100,
Bayer Vital, Leverkusen, Germany) was determined by
assessing the minimal inhibitory concentrations (MIC)s.
In case of GEN the E-test® (Viva Diagnostics, Cologne,
Germany) was used. The MIC of the FLU, ERY and CIP
was determined using a two-fold dilution starting with 2
μg/ml [10]. The MIC for GEN was 0.75 μg/ml, for CIP
0.25 μg/ml, for FLU 0.125 μg/ml and for ERY 1 μg/ml.
Bacterial supernatants were generated as described [5]. S.
aureus concentration was determined by the McFarland
values. A McFarland of 0.5 corresponds to approximately
1.5 × 108 bacteria/ml. S. aureus was incubated in complete
medium at a starting concentration of 1 × 107/ml for two
hours at 37°C. Subsequently, antibiotics were added at a
concentration of 1 × MIC or 20 × MIC for 4 hours. After
incubation, the supernatants were collected and sterile fil-
tered (0.45 μm, Millipore, Schwalbach, Germany).
To check the killing effect of the antibiotics, bacterial sus-
pensions were spread on COS blood agar plates after the
4 hours incubation with antibiotics. Colonies were
counted after an overnight incubation (Table 1). Flucloxa-
cillin, gentamicin and ciprofloxacin exerted a marked bac-
tericidal effect whereas erythromycin was basically
bacteriostatic.
Determination of LTA-content of bacterial supernatants
An ELISA was performed to determine the concentration
of LTA in the bacterial supernatants [6]. Highly purified
LTA of S. aureus at concentrations of 31 to 2000 ng/ml in
complete medium was used to set a standard curve. The
samples were incubated overnight at room temperature in
a 96-well PolySorb™ immunoplate (Nunc, Wiesbaden,
Germany). The plates were blocked with PBS + 0.5 % BSA
+ 0.05 % Tween 20 for one hour followed by three wash
steps with PBS + 0.05 % Tween 20. For detection, a mouse
IgG3 anti-LTA mAb (IgG3, clone 55, Hbt, AA Uden, The
Netherlands) was added at a concentration of 1.2 μg/ml
diluted in PBS + 0.5 % BSA. After an incubation for one
hour at 37°C the plates were washed and incubated with
2 μg/ml goat-anti-mouse Ig-HRP conjugate (Dako, Ham-
burg, Germany) for 90 min. After three washing steps
TMB substrate (BD Biosciences, Heidelberg, Germany)
was added. The reaction was stopped after 15 min with 2
Table 1: Effect of various antibiotics on the bacterial counts in cultures of S. aureus. S. aureus (DSM 20233 strain) bacteria were 
incubated in complete medium for 4 hours in the presence of antibiotics. Subsequently, bacterial suspensions were spread on COS 
blood agar plates. Colonies were counted after an overnight incubation.
Treatment bacteria/ml
starting concentration 4 × 106
4 hours without antibiotics 5.1 × 107
4 hours with 1 × MIC flucloxacillin 1.8 × 105
4 hours with 1 × MIC ciprofloxacin 2.5 × 103
4 hours with 1 × MIC gentamicin 5.2 × 105
4 hours with 1 × MIC erythromycin 8.3 × 105
4 hours with 20 × MIC flucloxacillin 10
4 hours with 20 × MIC ciprofloxacin 0
4 hours with 20 × MIC gentamicin 0
4 hours with 20 × MIC erythromycin 5.9 × 105Annals of Clinical Microbiology and Antimicrobials 2006, 5:15 http://www.ann-clinmicrob.com/content/5/1/15
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N H2SO4 (Merck, Darmstadt, Germany). The absorption
was measured at 450 nm. The detection limit of the assay
was 62 pg/ml.
Depletion of LTA from bacterial supernatants
In order to investigate whether LTA was the PMN-activat-
ing component of the bacterial supernatants LTA was
depleted from the supernatants. Protein G Sepharose 4
fast flow beads (Amersham Bioscience, Heidelberg, Ger-
many) were coated with the anti-LTA mAb. 80 μl of a sus-
pension of Protein G Sepharose beads were centrifuged at
15,300 × g for 20 sec, the pellet was washed three times
with PBS and resuspended in 80 μl PBS. 40 μl of the Pro-
tein G Sepharose suspension were incubated with 70 μl
anti-LTA mAb (antibody stock concentration > 200 μg/
ml) for one hour at 4°C. The remaining 40 μl of Protein
G Sepharose suspension were incubated with PBS as con-
trol in a glass vial for one hour at 4°C under continuous
shaking. The suspensions were centrifuged and the pellets
(Protein G-Ab-complex) were washed four times with
PBS. To deplete LTA from the supernatants, pellets were
resuspended in 250 μl supernatants from flucloxacillin-
treated (20 × MIC) bacteria and incubated for 45 min at
4°C under continuous shaking. The Sepharose bead sus-
pensions were centrifuged and the supernatants were
taken. The depletion procedure was repeated once more
with freshly prepared anti-LTA-Sepharose beads. Finally,
the LTA depleted supernatant was centrifuged two times
to remove the Sepharose beads. The efficacy of the LTA
depletion was 80 % as assessed in a LTA-ELISA by measur-
ing the LTA-content in the supernatants before and after
depletion. PMN were incubated with the LTA-depleted,
control (only protein G Sepharose treated) or untreated
supernatant.
Statistical analysis
Data are presented as mean ± standard deviation (SD) and
analyzed using JMP™ statistical software (Version 5.1 SAS
Institute, Cary, NC) or GraphPadPrism® (Version 4.01,
San Diego, CA). Data were tested for homoscedasticity
(homogenous variances of the data sets) with the Bartlett
test and for normal distribution with the Shapiro-Wilks
W-test. When both assumptions were met the data were
analyzed by one-way analysis (ANOVA) and a post test,
Tukey-Kramer for comparison of all pairs or Dunnett for
pair wise comparison with the control. If the variances
were not equal the transformation (log10 (x + 0.5)) was
performed. When after the transformation the assump-
tions were fulfilled the data were analyzed by ANOVA as
described before. However, if the assumptions were not
met, a non-parametric analysis was performed, the
Kruskal-Wallis for multiple comparisons test followed by
a Dunns post test. Overall, differences were considered
statistically significant at p < 0.05 and are indicated with
an asterisk.
Results
In this study the question was addressed whether expo-
sure of S. aureus to β-lactam antibiotics or antibiotics of
other groups leads to the generation of PMN-stimulating
activity and whether this activity can be attributed to LTA.
S. aureus bacteria were exposed to the β-lactam antibiotic
flucloxacillin, to erythromycin or gentamicin, both pro-
tein synthesis-inhibitors, or to ciprofloxacin, a gyrase
inhibitor. In preliminary experiments it was tested
whether the antibiotics alone exhibited an effect on PMN.
Flucloxacillin, gentamicin, erythromycin and cipro-
floxacin had no effect on PMN regarding their morphol-
ogy, apoptosis and cytokine release (data not shown).
PMN acquire an activated cell shape after exposure to bacte- rial supernatants Figure 1
PMN acquire an activated cell shape after exposure 
to bacterial supernatants. PMN (5 × 106/ml) were incu-
bated overnight in medium alone (A) or in supernatants of S. 
aureus exposed to flucloxacillin 20 × MIC (B), erythromycin 
20 × MIC (C), gentamicin 20 × MIC (D), ciprofloxacin 1 × 
MIC (E) or ciprofloxacin 20 × MIC (F). Elongated cell mor-
phology (arrows) is a sign for activation of PMN (original 
magnification 200 ×).
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Neutrophil granulocytes acquire an activated cell 
morphology upon exposure to supernatants of antibiotic-
treated S. aureus
Neutrophil activation is associated with marked changes
in cell morphology. Typically, activated PMN appear as
elongated, motile cells [11,12]. PMN were incubated with
supernatants of antibiotic-exposed S. aureus. We observed
that PMN acquired such activated elongated cell shape
upon exposure to supernatants of flucloxacillin-treated S.
aureus (Fig. 1B). A moderate activation was also observed
when PMN were coincubated with supernatants of cipro-
floxacin-exposed (1 × MIC) bacteria (Fig. 1E). Interest-
ingly, PMN incubated with supernatants of 20 × MIC
ciprofloxacin-exposed bacteria did no show activated cell
morphology (Fig. 1F). No activated cells were seen in cul-
tures of PMN after co-incubation with supernatants of
erythromycin- or gentamicin-exposed bacteria (Fig. 1C,
D). These morphological observations indicate that PMN-
activating substance(s) are released from S. aureus upon
treatment with flucloxacillin and, to a lesser degree, with
ciprofloxacin.
Neutrophil granulocytes release IL-8 after co-incubation 
with supernatants of antibiotic-exposed S. aureus
Neutrophil granulocytes are the major source of the
proinflammatory chemokine IL-8 [13]. Therefore, IL-8
release by PMN was assessed upon exposure to superna-
tants of antibiotic-treated S. aureus cultures overnight.
Supernatants of flucloxacillin-exposed bacteria induced
high levels of IL-8 secretion (Fig. 2). A lower level of IL-8
secretion was induced by supernatants of ciprofloxacin-
exposed S. aureus. Supernatants of gentamicin- or erythro-
mycin-treated S. aureus did not induce IL-8 release in cul-
tures of human PMN (Fig. 2). These data indicate that IL-
8 release inducing substance(s) are in the supernatants of
flucloxacillin- and ciprofloxacin-exposed bacteria.
PMN apoptosis is delayed in the presence of supernatants 
of antibiotic-exposed S. aureus
Neutrophils undergo constitutive apoptosis when aged
both in vivo and in vitro. Apoptotic PMN exhibit typical
morphological features such as cell shrinkage and con-
densation of the nucleus [8,9]. Using these morphological
criteria the percentage of apoptotic PMN was determined
in cultures exposed to S. aureus supernatants. The percent-
age of apoptotic cells was strongly reduced when neu-
trophils were coincubated with supernatants of
flucloxacillin- (1 × or 20 × MIC) or ciprofloxacin- (1 ×
MIC) exposed bacteria as compared to the apoptosis rate
of PMN cultured in medium alone (Fig. 3). Supernatants
of gentamicin- or erythromycin-exposed S. aureus did not
affect the apoptosis of PMN (Fig. 3). It is known that con-
stitutive apoptosis is a feature of resting/non-activated
PMN. Once PMN are activated and engaged in function,
their apoptosis is delayed. Therefore, the inhibition of
PMN apoptosis through supernatants of flucloxacillin-
and ciprofloxacin-exposed S. aureus is a further proof for
PMN-activating substance(s) in these supernatants.
LTA is present in the PMN-activating bacterial 
supernatants
Data presented above indicate that supernatants of flu-
cloxacillin-exposed and, to a lesser degree, of cipro-
floxacin-exposed  S. aureus activate neutrophil
granulocytes. We addressed the question which compo-
nent of these supernatants is responsible for the activation
of granulocytes. A likely candidate was LTA, since in a pre-
vious study purified LTA was observed to activate PMN
[2]. The LTA content was measured in supernatants of S.
aureus with or without antibiotic exposure. High LTA con-
tent was detected in supernatants of flucloxacillin-
exposed bacteria (Fig. 4). A moderate level of LTA was also
present in ciprofloxacin-exposed (1 × MIC) S. aureus
supernatants. The other antibiotics did not significantly
induce LTA release from S. aureus. Since the LTA content
of the supernatants positively correlates with the PMN-
activating capacity, the data strongly suggest that LTA is at
least one of the PMN-activating components in the super-
natants.
Depletion of LTA from the supernatant reduces PMN 
activation
Depletion experiments were carried out to investigate
whether LTA is the PMN-activating component of S.
Bacterial supernatants induce the secretion of IL-8 by PMN Figure 2
Bacterial supernatants induce the secretion of IL-8 
by PMN. Neutrophils were incubated at 5 × 106/ml over-
night in medium alone or with supernatants of antibiotic-
exposed bacteria. The IL-8 content was measured by ELISA. 
The results are mean ± SD of three to eight experiments. 
Significant differences between treated and non-treated cul-
tures are indicated (Kruskal-Wallis test, Dunns test). FLU20 
= flucloxacillin 20 × MIC; FLU1 = flucloxacillin 1 × MIC; 
ERY20 = erythromycin 20 × MIC; ERY1 = erythromycin 1 × 
MIC; CIP20 = ciprofloxacin 20 × MIC; CIP1 = ciprofloxacin 1 
× MIC; GEN20 = gentamicin 20 × MIC; GEN1 = gentamicin 1 
× MIC.
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aureus supernatants. LTA was depleted from the superna-
tant with the highest LTA content (flucloxacillin 20 ×
MIC) as described in the Methods. Using this technique
the LTA content of the supernatant was reduced by 80 %
(Fig. 5A). Co-incubation of PMN with LTA-depleted
supernatants led to a marked decrease in IL-8 release as
compared to incubation with LTA-containing superna-
tants (Fig. 5B). The number of cells with activated mor-
phology was also reduced when the cells were incubated
with the LTA-depleted supernatants (data not shown).
These data indicate that LTA is a major PMN-activating
component in supernatants of flucloxacillin-exposed S.
aureus.
LTA-containing bacterial supernatants enhance the 
phagocytic activity of neutrophil granulocytes
Phagocytosis of pathogenic microorganisms is one of the
most important effector functions of neutrophil granulo-
cytes. Having observed that LTA-containing supernatants
of flucloxacillin-treated bacteria activate PMN, we
addressed the question whether these activated granulo-
cytes are more potent regarding the phagocytosis of S.
aureus. Neutrophil granulocytes were incubated in
medium alone, stimulated with LTA or LTA-containing
supernatants of flucloxacillin- (20 × MIC) exposed bacte-
ria for 75 min at 37°C. Subsequently, viable S. aureus of
three strains (the reference strain DSM 20233 and two
clinical isolates) were added at a bacterium to PMN ratio
of 3:1 and the uptake of bacteria was assessed in a 30 min
phagocytosis assay. Both highly purified LTA and superna-
tants of flucloxacillin-exposed bacteria enhanced mark-
edly the phagocytic activity of PMN (Fig. 6). These data
indicate that the LTA-containing bacterial supernatants
not only activate PMN as assessed by morphological
changes, IL-8 release and apoptosis delay but also
enhance their phagocytic activity.
Discussion
We report that S. aureus release neutrophil-activating sub-
stance(s) upon exposure to the β-lactam antibiotic flu-
cloxacillin and, to a lesser degree, to the gyrase inhibitor
ciprofloxacin. We show data that supernatants of antibi-
otic-exposed S. aureus induce morphological changes and
IL-8 release in cultures of highly purified human PMN.
Moreover, exposure to S. aureus supernatants delays the
spontaneous apoptosis and enhances the phagocytic
capacity of PMN. We present evidence that lipoteichoic
acid (LTA) is a major PMN-activating component present
in supernatants of antibiotic-exposed S. aureus.
PMN are phagocytic cells that participate in innate
immune responses as a first line of defense against micro-
bial pathogens. S. aureus, a gram-positive bacterium, is
known to activate PMN functions leading to phagocytosis
and in most cases to killing of the ingested bacteria. How-
ever, it is still poorly characterized which component of S.
aureus is the most potent PMN-activating molecule. Com-
pared to LPS from gram-negative bacteria [14], the molec-
ular basis of LTA-mediated PMN activation is poorly
understood. Although in a previous study LTA was not
identified as PMN-activating component of S. aureus
supernatants [15] we have recently reported, that highly
purified S. aureus LTA exerts a direct stimulatory effect on
human PMN in a TLR2- and CD14-dependent manner
[2]. LTA is a component of the cell-membrane of gram-
positive bacteria. Treatment with β-lactam antibiotics that
interfere with the cell wall biosynthesis of the bacteria was
reported to induce release of LTA from S. aureus [5]. There-
fore, we hypothesized, that LTA-containing supernatants
of β-lactam-antibiotic-exposed S. aureus exert a stimula-
tory effect on human PMN. The data presented in this
work proved the hypothesis. Upon exposure to superna-
tants of flucloxacillin-treated S. aureus PMN acquired an
activated cell shape and released significant amounts of
IL-8. After pathogen challenge, IL-8 is one of the most
important chemotactic factors that mediate local neu-
trophil recruitment [13]. The autocrine production of IL-
8 by activated PMN is regarded as an amplifying loop to
attract more neutrophils to the site of infection [16]. In an
in vivo study intranasal application of LTA led to the
recruitment of PMN in the murine lung [17]. Although it
can not be excluded that LTA exerts a direct chemotactic
Bacterial supernatants delay the apoptosis of neutrophil gran- ulocytes Figure 3
Bacterial supernatants delay the apoptosis of neu-
trophil granulocytes. PMN (5 × 106/ml) were cultured in 
medium or with supernatants of antibiotic-exposed bacteria. 
After overnight co-incubation the percentage of apoptotic 
PMN was determined by microscopical evaluation of > 200 
cells on cytocentrifuge preparations stained with Giemsa. 
Results are mean ± SD of three to nine experiments. Signifi-
cant differences between treated and non-treated cultures 
are indicated (Kruskal-Wallis test, nns test). FLU20 = flu-
cloxacillin 20 × MIC; FLU1 = flucloxacillin 1 × MIC; ERY20 = 
erythromycin 20 × MIC; ERY1 = erythromycin 1 × MIC; 
CIP20 = ciprofloxacin 20 × MIC; CIPi1 = ciprofloxacin 1 × 
MIC; GEN20 = gentamicin 20 × MIC; GEN1 = gentamicin 1 × 
MIC.
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activity on PMN, the massive neutrophil accumulation in
the murine model is likely to be a result of chemotactic
factors released locally upon exposure to LTA. Indeed, an
increased level of KC, the murine functional homologue
of IL-8, was measured in the lung after treatment with LTA
[17]. Our previous data showed a high IL-8 release by
PMN after exposure to LTA [2]. This finding indicates that
after exposure to LTA and to LTA-containing supernatants,
PMN-derived IL-8 participates in the recruitment of more
PMN to the site of infection.
S. aureus and LTA were previously shown to stimulate the
cytokine production of monocytes [18]. These cytokines
include several proinflammatory cytokines which all are
known to possess the capacity to stimulate PMN. The goal
of our study was to investigate the direct effects of antibi-
otic-exposed S. aureus supernatants on PMN. Therefore,
indirect effects of LTA mediated by monocytes had to be
ruled out, i.e. special care had to be taken to avoid mono-
cyte contamination. Our technique for PMN isolation
resulted in a highly pure granulocyte population contain-
ing solely two or less monocytes per 10,000 granulocytes
[2]. The marked biological effect of LTA-containing super-
natants on this highly pure PMN population strongly
argues against a possible indirect effect mediated by solu-
ble factors released by contaminating leukocytes other
then PMN.
PMN are inherently short-lived cells with a half-life of
only about 6–10 hours, after which they undergo sponta-
neous apoptosis [8]. The life span of neutrophils can be
extended in vitro by incubation with either proinflamma-
tory cytokines including GM-CSF and G-CSF, IL-8, IL-1β,
or bacterial products such as LPS and fMLP [19,20]. This
implies that PMN die rapidly via apoptosis if not engaged
in function. After activation, however, inflammatory PMN
have an extended life span that enables these cells to exe-
cute their antimicrobial effector functions. Co-incubation
of PMN with purified S. aureus LTA was shown to activate
PMN leading to enhanced life span [2]. Here we show that
upon treatment with flucloxacillin or ciprofloxacin but
not with gentamicin or erythromycin S. aureus release
substances into the supernatant that delay PMN apopto-
sis. Since the apoptosis-delaying activity of the superna-
tants correlated with their LTA-content we conclude that
antibiotics that induce LTA release can expand the func-
tional longevity of neutrophil granulocytes.
The results presented here are in line with the data of van
Langevelde et al. [6] concerning the different effects of
antibiotics on the LTA release by S. aureus. Flucloxacillin
exposure induced LTA release by S. aureus whereas eryth-
romycin and gentamicin did not. The exact mechanism of
how antibiotic treatment leads to LTA release is still
unknown. Pollack et al. suggested that membrane vesicles
containing LTA are formed and extruded by the action of
β-lactam antibiotics. This way of LTA-release appears to be
independent of bacteriolysis [21]. On the other hand β-
lactam antibiotics inhibit the bacterial cell wall synthesis.
The accumulation of cell wall precursors was reported to
reduce the stability of LTA in the cell membrane [22]. As
LTA binds and inhibits autolytic enzymes in the cell wall
[23], an enhanced release of LTA could reduce the inhibi-
tion of autolytic enzymes and, consequently, could result
in bacteriolysis. We showed that treatment with a low
concentration of ciprofloxacin also exhibited a moderate
increase in LTA release by S. aureus. As described previ-
ously with gram-negative bacteria, ciprofloxacin treat-
ment can induce endotoxin release [24]. Others showed
that at low concentrations trovafloxacin, another qui-
nolone, induced the release of LTA and teichoic acids
from the gram-positive bacterium Streptococcus pneumo-
niae [4]. Although the primary mechanism of quinolone
action is the inhibition of DNA gyrase activity, it was
reported that exposure to low concentrations of quinolo-
nes led to the induction of bacteriolysis [25]. This mecha-
nism is a likely explanation why low-dose ciprofloxacin
treatment of S. aureus resulted in an enhanced release of
LTA and, consequently, to activation of PMN.
In the supernatants of antibiotic-exposed S. aureus the LTA
concentration was below 1 μg/ml. Still, regarding their
PMN-activating capacity, these supernatants were as
S. aureus release LTA after treatment with antibiotics Figure 4
S. aureus release LTA after treatment with antibiot-
ics. S. aureus were exposed to antibiotics for four hours. The 
bacterial supernatants were collected and sterile filtered. The 
LTA content of the supernatants was measured with an LTA-
specific ELISA. Data are expressed as mean ± SD of three 
experiments. Significant differences between treated and 
non-treated cultures are indicated (transformation log10(x + 
0.5), ANOVA, Dunnetts post test). FLU20 = flucloxacillin 20 
× MIC; FLU1 = flucloxacillin 1 × MIC; ERY20 = erythromycin 
20 × MIC; ERY1 = erythromycin 1 × MIC; CIP20 = cipro-
floxacin 20 × MIC; CIP1 = ciprofloxacin 1 × MIC; GEN20 = 
gentamicin 20 × MIC; GEN1 = gentamicin 1 × MIC.
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potent as 10 μg/ml purified LTA. On the one hand, a
reduction of biological activity during the purification
process of LTA may be a reason for this discrepancy.
Indeed, various biochemical alterations which could be
happen during purification [7] or through enzymatic deg-
radation [26] were shown to reduce the cytokine-inducing
capacities of cell wall components. On the other hand,
LTA is certainly one of several bacterial constituents
released after antibiotic-treatment from S. aureus. Cell
wall components such as peptidoglycan and teichoic acid
were shown to be present in bacterial supernatants [27].
Moreover, bacterial supernatants likely contain several
additional bacterial products. These various factors often
act on leukocytes in a synergistic way, as demonstrated for
muramyldipeptide (N-acetylmuramyl-L-alanyl-D-iso-
glutamine) with LTA [28]. Muramyldipeptide is the mini-
mal essential structure of peptidoglycan exerting
biological activity. Therefore, the high biological activity
of supernatants from antibiotic-exposed S. aureus is likely
a consequence of synergistic actions of various bacterial
components. However, our depletion experiments clearly
indicated that LTA is a major and essential PMN-activat-
ing component of S. aureus supernatants.
Once recruited at inflamed sites, PMN recognize and
phagocytose gram-positive bacteria resulting in the activa-
tion of these antimicrobial effector cells [3]. Here it was
shown that, in addition to highly purified LTA, LTA-con-
taining supernatants of S. aureus also upregulated the
phagocytic activity of PMN. Therefore, LTA enhances the
ability of PMN to kill the bacteria and to clear the infec-
LTA enhances the phagocytic activity of PMN Figure 6
LTA enhances the phagocytic activity of PMN. Neu-
trophil granulocytes were incubated for 75 minutes at 37°C 
in medium alone or in the presence of LTA (10 μg/ml) or in 
the presence of a supernatant of flucloxacillin (20 × MIC)-
exposed S. aureus. Subsequently, viable S. aureus (3:1; bacte-
ria:PMN) of three strains (the reference strain DSM 20233 
and two clinical isolates) were added and the cells incubated 
for an additional 30 minutes at 37°C. The number of PMN 
with phagocytosed S. aureus was assessed on Giemsa-stained 
cytocentrifuge slides under oil immersion light microscopy. 
Data (mean ± SD) of three independent experiments are 
shown. Significant differences (ANOVA, Dunnets test) to 
unstimulated PMN are indicated (*)
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Depletion of LTA results in the reduction of PMN-activating  capacity of S. aureus supernatants Figure 5
Depletion of LTA results in the reduction of PMN-
activating capacity of S. aureus supernatants. A) LTA 
was depleted from flucloxacillin-exposed (20 × MIC, FLU20) 
S. aureus supernatants as described in Materials and Methods. 
LTA content was measured before and after LTA-depletion 
using an ELISA. Data are expressed as mean ± SD of three 
experiments. *Asterisk indicates significant difference (trans-
formation log10(x + 0.5), ANOVA, Dunnetts post test). B) 
Neutrophils were incubated at 5 × 106/ml overnight in 
medium alone, with the LTA-containing or the LTA-depleted 
bacterial supernatants. The IL-8 content in the PMN superna-
tants was measured using ELISA. Data are expressed as mean 
± SD of three experiments. Significant difference was ana-
lyzed after a transformation log10(x + 0.5) by ANOVA and 
Tukey-Kramer post test.
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tion. Treatment with β-lactam antibiotics and, to a lesser
degree with gyrase inhibitors, can enhance the efficiency
of innate immune mechanisms through the activation of
neutrophil granulocytes. In addition, the prolonged life
span permits PMN to exert their enhanced ability to fight
against gram-positive bacteria for a longer period of time.
Activated granulocytes are essential components of the
antimicrobial innate defense. Nevertheless, it should be
kept in mind that granulocytes can be the cause of severe
pathological conditions through tissue damage [29].
Since local LTA release can lead to PMN recruitment
[17,30], local PMN-mediated reactions could trigger
severe pathology if the bacterial infection is not efficiently
cleared. However, our data show that antibiotic-treated
rather than intact/viable S. aureus release significant
amounts of LTA. The antibiotics that induce LTA-release
are effective to kill the bacteria and, therefore, limit the
persistence of these pathogens in the infected tissue.
Therefore, the beneficial effects of antibiotic-induced LTA-
release and the consequent PMN-activation are likely to
exceed the potential tissue destruction through activated
granulocytes.
Conclusion
The presented data indicate that LTA is one major PMN-
activating component in the supernatants of antibiotic-
treated S. aureus. Treatment of S. aureus infections with β-
lactam antibiotics that induce LTA release has, in addition
to the direct antibacterial activity, an activating effect on
the innate immune system. Local LTA release can lead to
recruitment and activation of neutrophil granulocytes at
the site of infection. The extended life span and enhanced
phagocytic activity of PMN can contribute to a more effi-
cient resolution of the infection.
Abbreviations
CIP, ciprofloxacin; ERY, erythromycin; FLU, flucloxacillin;
GEN, gentamicin; LTA, lipoteichoic acid; MIC, minimal
inhibitory concentration; PMN, polymorphonuclear neu-
trophil granulocytes
Declaration of competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
SL carried out most experiments with human granulo-
cytes, measured and depleted LTA in culture supernatants
and drafted the manuscript. AS cultivated the S. aureus
strains. CZ analyzed PMN apoptosis. SM and TH purified
LTA from S. aureus and contributed to the experimental
design. WS critically revised the manuscript for important
intellectual content. TL conceived of the study, partici-
pated in its design and coordination and helped to draft
the manuscript
Acknowledgements
This work was supported by grants from the Deutsche Forschungsgesells-
chaft to TL and WS (La1267/1-2; SFB 367/B10) and from the Medical Fac-
ulty of the University of Luebeck to TL (SP Infektabwehr/B1). The authors 
thank Dr. Ger van Zandbergen for fruitful discussions, Sonja Dannenberg 
and the staff of the Varia Laboratory at the Institute for Medical Microbiol-
ogy and Hygiene at the University of Luebeck for excellent technical assist-
ance.
References
1. Lowy FD: Staphylococcus aureus infections.  N Engl J Med 1998,
339:520-532.
2. Lotz S, Aga E, Wilde I, van Zandbergen G, Hartung T, Solbach W,
Laskay T: Highly purified lipoteichoic acid activates neutrophil
granulocytes and delays their spontaneous apoptosis via
CD14 and TLR2.  J Leukoc Biol 2004, 75:467-477.
3. Vandenbroucke-Grauls CM, Thijssen HM, Verhoef J: Interaction
between human polymorphonuclear leucocytes and Staphy-
lococcus aureus in the presence and absence of opsonins.
Immunology 1984, 52:427-435.
4. Stuertz K, Schmidt H, Eiffert H, Schwartz P, Mader M, Nau R: Differ-
ential release of lipoteichoic and teichoic acids from Strepto-
coccus pneumoniae as a result of exposure to beta-lactam
antibiotics, rifamycins, trovafloxacin, and quinupristin-dalfo-
pristin.  Antimicrob Agents Chemother 1998, 42:277-281.
5. Utsui Y, Ohya S, Takenouchi Y, Tajima M, Sugawara S, Deguchi K, Sug-
inaka H: Release of lipoteichoic acid from Staphylococcus
aureus  by treatment with cefmetazole and other beta-
lactam antibiotics.  J Antibiot (Tokyo) 1983, 36:1380-1386.
6. van Langevelde P, van Dissel JT, Ravensbergen E, Appelmelk BJ, Schr-
ijver IA, Groeneveld PH: Antibiotic-induced release of lipotei-
choic acid and peptidoglycan from Staphylococcus aureus:
quantitative measurements and biological reactivities.  Anti-
microb Agents Chemother 1998, 42:3073-3078.
7. Morath S, Geyer A, Hartung T: Structure-function relationship
of cytokine induction by lipoteichoic acid from Staphylococ-
cus aureus.  J Exp Med 2001, 193:393-397.
8. Payne CM, Glasser L, Tischler ME, Wyckoff D, Cromey D, Fiederlein
R, Bohnert O: Programmed cell death of the normal human
neutrophil: an in vitro model of senescence.  Microsc Res Tech
1994, 28:327-344.
9. Squier MK, Sehnert AJ, Cohen JJ: Apoptosis in leukocytes.  J Leukoc
Biol 1995, 57:2-10.
10. Burkhardt F: Mikrobiologische Diagnostik Stuttgart: Georg Thieme Ver-
lag; 1992. 
11. Klut ME, Whalen BA, Hogg JC: Activation-associated changes in
blood and bone marrow neutrophils.  J Leukoc Biol 1997,
62:186-194.
12. Stickle JE: The neutrophil. Function, disorders, and testing.  Vet
Clin North Am Small Anim Pract 1996, 26:1013-1021.
13. Cassatella MA: Neutrophil-derived proteins: selling cytokines
by the pound.  Adv Immunol 1999, 73:369-509.
14. Wilson ME: Effects of bacterial endotoxins on neutrophil func-
tion.  Rev Infect Dis 1985, 7:404-418.
15. Veldkamp KE, van Kessel KP, Verhoef J, van Strijp JA: Staphylococ-
cal culture supernates stimulate human phagocytes.  Inflam-
mation 1997, 21:541-551.
16. Gainet J, Chollet-Martin S, Brion M, Hakim J, Gougerot-Pocidalo MA,
Elbim C: Interleukin-8 production by polymorphonuclear neu-
trophils in patients with rapidly progressive periodontitis: an
amplifying loop of polymorphonuclear neutrophil activation.
Lab Invest 1998, 78:755-762.
17. von Aulock S, Morath S, Hareng L, Knapp S, van Kessel KP, van Strijp
JA, Hartung T: Lipoteichoic acid from Staphylococcus aureus is
a potent stimulus for neutrophil recruitment.  Immunobiol
2003, 208:413-422.
18. Ellingsen E, Morath S, Flo T, Schromm A, Hartung T, Thiemermann C,
Espevik T, Golenbock D, Foster D, Solberg R, Aasen A, Wang J:
Induction of cytokine production in human T cells and
monocytes by highly purified lipoteichoic acid: involvementPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Annals of Clinical Microbiology and Antimicrobials 2006, 5:15 http://www.ann-clinmicrob.com/content/5/1/15
Page 10 of 10
(page number not for citation purposes)
of Toll-like receptors and CD14.  Med Sci Monit 2002,
8:BR149-BR156.
19. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A: Modulation
ofgranulocyte survival and programmed cell death by
cytokines and bacterial products.  Blood 1992, 80:2012-2020.
20. Lee A, Whyte MK, Haslett C: Inhibition of apoptosis and prolon-
gation of neutrophil functional longevity by inflammatory
mediators.  J Leukoc Biol 1993, 54:283-288.
21. Pollack JH, Ntamere AS, Neuhaus FC: D-alanyl-lipoteichoic acid
in Lactobacillus casei: secretion of vesicles in response to ben-
zylpenicillin.  J Gen Microbiol 1992, 138:849-859.
22. Tomasz A, Waks S: Mechanism of action of penicillin: trigger-
ing of the pneumococcal autolytic enzyme by inhibitors of
cell wall synthesis.  Proc Natl Acad Sci USA 1975, 72:4162-4166.
23. Suginaka H, Shimatani M, Ogawa M, Kotani S: Prevention of peni-
cillin-induced lysis of Staphylococcus aureus by cellular
lipoteichoic acid.  J Antibiot (Tokyo) 1979, 32:73-77.
24. Crosby HA, Bion JF, Penn CW, Elliott TS: Antibiotic-induced
release of endotoxin from bacteria in vitro.  J Med Microbiol
1994, 40:23-30.
25. Vincent S, Glauner B, Gutmann L: Lytic effect of two fluoroqui-
nolones, ofloxacin and pefloxacin, on Escherichia coli W7 and
its consequences on peptidoglycan composition.  Antimicrob
Agents Chemother 1991, 35:1381-1385.
26. Timmerman CP, Mattsson E, Martinez-Martinez L, De GL, van Strijp
JA, Verbrugh HA, Verhoef J, Fleer A: Induction of release of
tumor necrosis factor from human monocytes by staphylo-
cocci and staphylococcal peptidoglycans.  Infect Immun 1993,
61:4167-4172.
27. Tuomanen E, Liu H, Hengstler B, Zak O, Tomasz A: The induction
of meningeal inflammation by components of the pneumo-
coccal cell wall.  J Infect Dis 1985, 151:859-868.
28. Yang S, Tamai R, Akashi S, Takeuchi O, Akira S, Sugawara S, Takada
H: Synergistic effect of muramyldipeptide with lipopolysac-
charide or lipoteichoic acid to induce inflammatory
cytokines in human monocytic cells in culture.  Infect Immun
2001, 69:2045-2053.
29. Witko-Sarsat V, Rieu P, Scamps-Latscha B, Lesavre P, Halbwachs-
Mecarelli L: Neutrophils: molecules, functions and pathophys-
iological aspects.  Lab Invest 2000, 80:617-653.
30. Leemans JC, Heikens M, van Kessel KP, Florquin S, van der Poll T:
Lipoteichoic acid and peptidoglycan from Staphylococcus
aureus synergistically induce neutrophil influx into the lungs
of mice.  Clin Diagn Lab Immunol 2003, 10:950-953.